FDA Will Mull OTC Smoking Cessation Long-Term Use As Support Builds
This article was originally published in The Tan Sheet
Executive Summary
Participants at an FDA workshop will consider issues that could influence whether the agency extends the use of nicotine-replacement therapies beyond the current 12-week indication